Reduced ischemia/reperfusion injury via glutathione-initiated nitric oxide-releasing dendrimers

Nitric Oxide - Biology and Chemistry

Volumn 22, Issue 1, 2010, Pages 30-36

  Johnson, Timothy A ^a   Stasko, Nathan A ^b   Matthews, Jessica L ^c   Cascio, Wayne E ^c   Holmuhamedov, Ekhson L ^d   Johnson, C Bryce ^d   Schoenfisch, Mark H ^b  

^a VIRGINIA TECH CARILION SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Dendrimer; Glutathione; Ischemia reperfusion injury; Nitric oxide; Nitrosothiol

Indexed keywords

DENDRIMER; GLUTATHIONE; MOLECULAR SCAFFOLD; NITRIC OXIDE; POLYAMIDOAMINE; S NITROSOTHIOL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; CELLS, CULTURED; DENDRIMERS; DISEASE MODELS, ANIMAL; GLUTATHIONE; MALE; NITRIC OXIDE; POLYAMINES; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

RATTUS;

EID: 73149095381     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.11.002     Document Type: Article

References (41)

1. C.P. Howson, K.S. Reddy, T.J. Ryan, J.R. Bale, in: Control of Cardiovascular Diseases in Developing Countries: Research, Development, and Institutional Strengthening, National Academy Press, Washington, DC, 1998, pp. 11-36.
2. Minino A.M., Heron M.P., Murphy A.L., and Kochanek M.A. Deaths: final data for 2004. Natl. Vital Stat. Rep. 55 (2007) 1-120
3. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury. New Engl. J. Med. 357 (2007) 1121-1135
4. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., Hochman J.S., Krumholz H.M., Lamas G.A., Mullany C.J., Pearle D.L., Sloan M.A., and Smith Jr. S.C. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 51 (2008) 210-247
5. Ignarro L.J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Angew. Chem. Int. Ed. 38 (1999) 1882-1892
6. Schulz R., Kelm M., and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovasc. Res. 61 (2004) 402-413
7. Bolli R., Becker L., Gross G., Mentzer R., Balshaw Jr. D., and Lathrop D.A. Myocardial protection at a crossroads: the need for translation into clinical therapy. Circ. Res. 95 (2004) 125-134
8. Razavi H.M., Hamilton J.A., and Feng Q. Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. Pharmacol. Ther. 106 (2005) 147-162
9. Liu X., Huang Y., Pokreisz P., Vermeersch P., Marsboom G., Swinnen M., Verbeken E., Santos J., Pellens M., Gillijns H., Van de Werf F., Bloch K.D., and Janssens S. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J. Am. Coll. Cardiol. 50 (2007) 808-817
10. Wang P.G., Xian M., Tang X., Wu X., Wen Z., Cai T., and Janczuk A.J. Nitric oxide donors: chemical activities and biological applications. Chem. Rev. 102 (2002) 1091-1134
11. Miller M.R., and Megson I.L. Recent developments in nitric oxide donor drugs. Br. J. Pharmacol. 151 (2007) 305-321
12. Scatena R., Bottoni R., Martorana G.E., and Giardina B. Nitric oxide donor drugs: an update on pathophysiology and therapeutic potential. Expert Opin. Investig. Drugs 14 7 (2005) 835-846
13. Hogg N. Biological chemistry and clinical potential of S-nitrosothiols. Free Radic. Biol. Med. 28 (2000) 1478-1486
14. Konorev E.A., Tarpey M.M., Joseph J., Baker J.E., and Kalyanaraman B. S-nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest-evidence for a cardioprotective effect of nitric oxide. J. Pharmacol. Exp. Ther. 274 (1995) 200-206
15. Bell R.M., Maddock H.L., and Yellon D.M. The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc. Res. 57 (2003) 405-415
16. Svenson S., and Tomalia D.A. Dendrimers in biomedical applications - reflections on the field. Adv. Drug Deliv. Rev. 57 (2005) 2106-2129
17. Cheng Y., and Xu T. The effect of dendrimers on the pharmacodynamic and pharmacokinetic behaviors of non-covalently or covalently attached drugs. Eur. J. Med. Chem. 43 (2008) 2291-2297
18. Taite L.J., and West J.L. Poly(ethylene glycol)-lysine dendrimers for targeted delivery of nitric oxide. J. Biomater. Sci. Polym. Ed. 17 (2006) 1159-1172
19. Stasko N.A., Fischer T.A., and Schoenfisch M.H. S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles. Biomacromolecules 9 3 (2008) 834-841
20. Singh R.J., Hogg N., Joseph J., and Kalanaraman B. Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem. 271 (1996) 18596-18603
21. Micheleet F., Gueguen R., Leroy P., Wellman M., Nicolas A., and Siest G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habitats. Clin. Chem. 41 (1995) 1509-1517
22. Beckman J.S., and Conger K.A. Direct measurement of nitric oxide in solutions with an ozone based chemiluminescent detector. Methods 7 (1995) 35-39
23. Stasko N.A., Johnson B., Schoenfisch M.H., Johnson T.A., and Holmuhamedov E.L. Cytotoxicity of polypropylenimine dendrimer conjugates on cultured endothelial cells. Biomacromolecules 8 (2007) 3853-3859
24. T.A. Johnson, J.L. Matthews, W.E. Cascio, M.H. Schoenfisch, N.A. Stasko, E. Holmuhamedov, C.B. Johnson, Novel dendritic nanoparticle delivery of the no donor SNAP reduces myocardial infarct size in isolated perfused rat hearts, NCBC Nanotechnology Conference (2008) abstract.
25. Stiriba E., Frey H., and Haag R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew. Chem. Int. Ed. 41 (2002) 1329-1334
26. Kolhe P., Khandare J., Pillai O., Kannan S., Lieh-Lai M., and Kannan R.M. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload. Biomaterials 27 (2006) 660-669
27. Gillies E.R., and Frechet J.M. Dendrimers and dendritic polymers in drug delivery. Drug Discov. Today 10 (2005) 35-43
28. Frechet J.M. Dendrimers and other dendritic macromolecules: from building blocks to functional assemblies in nanoscience and nanotechnology. J. Polym. Sci. A Polym. Chem. 41 (2003) 3713-3725
29. Majoros I.J., Thomas T.P., Mehta C.B., and Baker J.R. Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy. J. Med. Chem. 48 (2005) 5892-5899
30. Malik N., Evagorou E.G., and Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy. Anticancer Drugs 10 (1999) 767-776
31. Duncan R., and Izzo L. Dendrimer biocompatibility and toxicity. Adv. Drug Deliv. Rev. 57 (2005) 2215-2237
32. Xu A., Vita J.A., and Keaney Jr. J.F. Ascorbic acid and glutathione modulate the biological activity of S-nitrosoglutathione. Hypertension 36 (2000) 291-295
33. Hu T.M., and Chou T.C. The kinetics of thiol-mediated decomposition of S-nitrosothiols. AAPS J. 8 (2006) E485-E492
34. Singh S.P., Wishnok J.S., Keshive M., Deen W.M., and Tannenbaum S.R. The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl. Acad. Sci. USA 93 (1996) 14428-14433
35. Vriesman M.F., Haenen G.R., Westerveld G.J., Paquay J.B., Voss H.P., and Bast A. A method for measuring nitric oxide radical scavenging activity. Scavenging properties of sulfur-containing compounds. Pharm. World Sci. 19 (1997) 283-286
36. Hogg N., Singh R.J., and Kalyanaraman B. The role of glutathione in the transport and catabolism of nitric oxide. FEBS Lett. 382 (1996) 223-228
37. Folkes L.K., and Wardman P. Kinetics of the reaction between nitric oxide and glutathione: implications for thiol depletion in cells. Free Radic. Biol. Med. 37 (2004) 549-556
38. Yellepeddi V.K., Kumar A., and Palakurthi S. Surface modified poly(amido)amine dendrimers as diverse nanomolecules for biomedical applications. Expert Opin. Drug Deliv. 6 (2009) 835-850
39. Hogg N. The biochemistry and physiology of S-nitrosothiols. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 585-600
40. Kim J., Ohshima S., Pediaditakis P., and Lemasters J.J. Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 39 6 (2004) 1533-1543
41. Kim P.K., Kwon Y.G., Chung H.T., and Kim Y.M. Regulation of caspases by nitric oxide. Ann. NY Acad. Sci. 962 (2002) 42-52